Someone taking an antidepressant reaches for a diet soda without a second thought — sweetener and medication have always felt like two completely separate things. New lab research out of Cambridge suggests that assumption might not hold up: at least one common sweetener appears to behave very differently once it’s mixed with a specific drug.
Researchers at the University of Cambridge’s MRC Toxicology Unit tested 39 commercially used sweeteners against 25 species of gut bacteria, and found that most of them aren’t the biologically “invisible” substances they’re often marketed as.
Key Takeaways
- About three-quarters of the 39 sweeteners tested affected the growth of at least one gut bacteria species in lab experiments — including well-known ones like aspartame, sucralose, and stevia derivatives.
- The most dramatic effect came from combining isosteviol, a stevia-derived sweetener, with duloxetine, a widely prescribed antidepressant — together they sharply suppressed two beneficial gut bacteria species.
- Researchers found more than 100 cases where a sweetener behaved differently once combined with something else, like caffeine, flavorings, or medication.
- This is laboratory research only — done in bacterial cultures and cell models, not in people — so it doesn’t yet show these effects happen inside the human body.
What the Researchers Actually Did
The team grew 25 different species of gut bacteria separately in the lab, including some considered beneficial, some neutral, and some potentially harmful, then exposed each to 39 sweeteners to see whether their growth sped up, slowed down, or stopped. About three-quarters of the sweeteners changed the growth of at least one species — evidence, the researchers say, against the common assumption that sweeteners simply pass through the body without interacting with anything.
Because people rarely consume a sweetener completely on its own, the team then paired the sweeteners with other everyday substances — caffeine, vanilla flavoring, and eight commonly used drugs. That turned up more than 100 cases where a combination changed the sweetener’s effect, making it stronger in 34 cases and weaker in 68.
Why the Antidepressant Combination Stood Out
The starkest result came from pairing isosteviol, a compound derived from stevia, with duloxetine — an antidepressant also used for anxiety and certain chronic pain conditions, prescribed to more than 4.2 million people in the US in 2023. Together, the two compounds strongly suppressed two bacteria species, Roseburia intestinalis and Parabacteroides merdae, both considered important for digestive and metabolic health. Professor Kiran Patil, the study’s senior author, told Newsweek the team expected some interaction between the compounds, but not one this strong.
To get closer to how the gut actually works — as a crowded ecosystem rather than isolated species — the researchers also built a simplified community of all 25 bacteria together and exposed it to the same combinations. The isosteviol-duloxetine pairing reduced the community’s overall microbial diversity, a trait generally associated with a healthier, more resilient gut, and shifted the balance so some species thrived while others declined. Follow-up tests suggested the changes also increased toxicity toward certain host cells and affected immune-related cell activity.
What This Doesn’t Show Yet
It’s worth being precise about what this study can and can’t tell us. Every experiment here was done with bacteria and cell models in a lab setting, not in the human digestive system, where sweeteners get absorbed, broken down, and diluted in ways a test tube can’t replicate — and where diet, genetics, and a person’s existing gut bacteria all vary considerably. The researchers themselves are clear that this doesn’t prove sweeteners or this specific combination cause harm in people, and that human studies are the necessary next step to know whether these effects show up at real-world doses.
What’s Next
The researchers say their findings should guide future studies looking at whether these interactions actually occur in the human body, at what doses, and whether they produce any measurable health effects. For now, there’s no specific guidance to avoid sweeteners or this drug combination — just a reminder that “inactive” ingredients may be more biologically active than commonly assumed.
Source: Blasche, S., Periwal, V., et al. (2026). Common xenobiotics modulate gut microbial responses to low-calorie sweeteners in vitro. Molecular Systems Biology. DOI: 10.1038/s44320-026-00225-6.